Evidence map›Paper›PMID 26686985›Full record

ArticleLab on a chip2016

Generation and functional assessment of 3D multicellular spheroids in droplet based microfluidics platform.

P Sabhachandani, V Motwani, N Cohen, S Sarkar, V Torchilin, T Konry

Abstract read
In one paragraph

Article in Lab on a chip, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 187 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Engineering Heterogeneous Tumor Models for Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

P SabhachandaniDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu.
V MotwaniDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu.
N CohenDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu.
S SarkarDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu.
V TorchilinDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu and Center for Pharmaceutical Biotechnology & Nanomedicine, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA.
T KonryDepartment of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, 140 The Fenway, Boston, MA 02115, USA. t.konry@neu.edu.
Universidad del Noreste · MXNortheastern University · US

Funding

Development of Microfluidic Nano-Liter Platform for Single Cell Dynamic MonitorinR21CA174401 · NCI · NORTHEASTERN UNIVERSITY · PI KONRY, TANIA TALI · 2012 to 2013
$429k
NCI NIH HHS R21 CA174401RMOD NIH HHS R21 RM11-014
6 · The paper itself

Abstract

Here we describe a robust, microfluidic technique to generate and analyze 3D tumor spheroids, which resembles tumor microenvironment and can be used as a more effective preclinical drug testing and screening model. Monodisperse cell-laden alginate droplets were generated in polydimethylsiloxane (PDMS) microfluidic devices that combine T-junction droplet generation and external gelation for spheroid formation. The proposed approach has the capability to incorporate multiple cell types. For the purposes of our study, we generated spheroids with breast cancer cell lines (MCF-7 drug sensitive and resistant) and co-culture spheroids of MCF-7 together with a fibroblast cell line (HS-5). The device has the capability to house 1000 spheroids on chip for drug screening and other functional analysis. Cellular viability of spheroids in the array part of the device was maintained for two weeks by continuous perfusion of complete media into the device. The functional performance of our 3D tumor models and a dose dependent response of standard chemotherapeutic drug, doxorubicin (Dox) and standard drug combination Dox and paclitaxel (PCT) was analyzed on our chip-based platform. Altogether, our work provides a simple and novel, in vitro platform to generate, image and analyze uniform, 3D monodisperse alginate hydrogel tumors for various omic studies and therapeutic efficiency screening, an important translational step before in vivo studies.

Indexed as

Breast NeoplasmsCell Culture TechniquesMicrofluidic Analytical TechniquesModels, BiologicalAntineoplastic Combined Chemotherapy ProtocolsCell SurvivalDrug Screening Assays, AntitumorFemaleHumansMCF-7 CellsSpheroids, Cellular

Identifiers

PMID26686985
PMCPMC4834071
OpenAlexW2208720153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.